Home › Psychology Rejection › NCT01163578

Biomarkers in Transplant Recipients to Improve Outcomes

Study of Biomarkers in Solid Organ and Bone Marrow Transplant Recipients to Better Treat Rejection

Who can join

All ages · All sexes

Inclusion Criteria:

* Recipients of abdominal, thoracic and bone marrow allografts that are receiving inpatient and outpatient follow-up with routine laboratory tests at the University of Pittsburgh Medical Center.
* All Ages
* Subject or parents are able to read and understand the informed consent

Exclusion Criteria:

* Subjects and/or their parents who are unable to read and understand informed consent.

About the study

The objective of this study is to evaluate whether certain proteins, expressed in biological tissues can indict a better understanding of the effect of drugs that are used to treat rejection, and of processes leading to rejection and rejection-free outcomes.

Sponsor: University of Pittsburgh · Participants: 1,200 · Started: 2005-03

Contact the study team

• Morgan L Paul, BSN · Phone: 412-692-8472
• Daniel Pieratt, MPA · Phone: 412-692-6692

Official record on ClinicalTrials.gov — NCT01163578

Locations in the U.S.

Conditions

• Psychology Rejection

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.